A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for reciprocal marketing approval of certain drugs, biological products, and devices that are authorized to be lawfully marketed abroad, and for other purposes.
The bill’s titles are written by its sponsor.
Sponsor and status
Sponsor. Junior Senator for Texas. Republican.
Last Updated: Jul 18, 2019
Length: 8 pages
116th Congress (2019–2021)
This bill was introduced on July 18, 2019, in a previous session of Congress, but it did not receive a vote.
Although this bill was not enacted, its provisions could have become law by being included in another bill. It is common for legislative text to be introduced concurrently in multiple bills (called companion bills), re-introduced in subsequent sessions of Congress in new bills, or added to larger bills (sometimes called omnibus bills).
3 Cosponsors (3 Republicans)
Dec 10, 2015
Earlier Version — Introduced
This activity took place on a related bill, S. 2388 (114th).
Oct 26, 2017
Earlier Version — Introduced
This activity took place on a related bill, S. 2022 (115th).
Jul 18, 2019
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.
Feb 2, 2021
Reintroduced Bill — Introduced
This activity took place on a related bill, S. 154 (117th).
S. 2161 (116th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
Bills numbers restart every two years. That means there are other bills with the number S. 2161. This is the one from the 116th Congress.
This bill was introduced in the 116th Congress, which met from Jan 3, 2019 to Jan 3, 2021. Legislation not passed by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
GovTrack.us. (2023). S. 2161 — 116th Congress: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2019. Retrieved from https://www.govtrack.us/congress/bills/116/s2161
“S. 2161 — 116th Congress: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2019.” www.GovTrack.us. 2019. February 5, 2023 <https://www.govtrack.us/congress/bills/116/s2161>
Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2019, S. 2161, 116th Cong..
|title=S. 2161 (116th)
|accessdate=February 5, 2023
|author=116th Congress (2019)
|date=July 18, 2019
|quote=Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2019
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.